Trex Wind Down, Inc. financial data

Industry
Pharmaceutical Preparations
Location
3 Mountainview Road, Suite 100, Warren, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Timber Pharmaceuticals, Inc. (to 1/26/2024), BioPharmX Corp (to 5/15/2020), THOMPSON DESIGNS INC (to 2/18/2014)
Latest financial report
10-Q - Q2 2023 - Aug 21, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 149 % -43.6%
Debt-to-equity 183 % +129%
Return On Equity -517 % -77.1%
Return On Assets -183 % -17.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.09M shares +3.87%
Common Stock, Shares, Outstanding 3.05M shares -95.2%
Entity Public Float 20M USD -55.2%
Common Stock, Value, Issued 148K USD +133%
Weighted Average Number of Shares Outstanding, Basic 3.08M shares +142%
Weighted Average Number of Shares Outstanding, Diluted 3.08M shares +142%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.73M USD -2.04%
Operating Income (Loss) -14.7M USD +19.9%
Nonoperating Income (Expense) -235K USD -393%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.07M USD -64%
Net Income (Loss) Attributable to Parent -14.9M USD +18.5%
Earnings Per Share, Basic -1.97 USD/shares +89.6%
Earnings Per Share, Diluted -9.19 USD/shares +31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.52M USD -69.5%
Other Assets, Current 133K USD -44%
Assets, Current 2.79M USD -69.9%
Deferred Income Tax Assets, Net 83.3K USD -50.2%
Property, Plant and Equipment, Net 18.7K USD -9.1%
Operating Lease, Right-of-Use Asset 371K USD -23.1%
Assets 3.33M USD -66.4%
Accounts Payable, Current 1.63M USD +288%
Accrued Liabilities, Current 2.02M USD +43.4%
Liabilities, Current 5.62M USD -14.4%
Operating Lease, Liability, Noncurrent 323K USD +96.8%
Other Liabilities, Noncurrent 73.7K USD 0%
Liabilities 5.95M USD -30.5%
Retained Earnings (Accumulated Deficit) -56.4M USD -36%
Stockholders' Equity Attributable to Parent -2.62M USD -294%
Liabilities and Equity 3.33M USD -66.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.9M USD -32.5%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -1.96K USD +44.3%
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 3.05M shares -95.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.52M USD -69.5%
Deferred Tax Assets, Valuation Allowance 37.2M USD +15.4%
Deferred Tax Assets, Gross 37.3M USD +15%
Operating Lease, Liability 545K USD +7.88%
Depreciation 1.29K USD +63.5%
Payments to Acquire Property, Plant, and Equipment 1.96K USD -44.3%
Lessee, Operating Lease, Liability, to be Paid 691K USD +22.7%
Operating Lease, Liability, Current 222K USD -34.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 110K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 108K USD -69.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 145K USD +152%
Lessee, Operating Lease, Liability, to be Paid, Year Three 113K USD
Deferred Tax Assets, Operating Loss Carryforwards 29.2M USD +6.89%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 116K USD
Operating Lease, Payments 105K USD +6.81%
Additional Paid in Capital 53.6M USD +25.5%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 666K USD -43.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares